Alpha Tau Medical (DRTS) CFO sells 20,000 Ordinary Shares

Rhea-AI Filing Summary

Alpha Tau Medical Ltd. Chief Financial Officer Raphi Levy reported open-market sales of 20,000 Ordinary Shares on June 25, 2026. The shares were sold in two transactions at a price of about $11.0002 per share. These transactions reflect a net reduction in his directly held shares.

Insider Trade Summary 10b5-1

Net Seller: 20,000 shares ($220,004)

Net Sell 2 txns

Insider Levy Raphi

Role Chief Financial Officer

Sold 20,000 shs ($220K)

Type	Security	Shares	Price	Value
Sale	Ordinary Shares	4,222	$11.0002	$46K
Sale	Ordinary Shares	15,778	$11.0002	$174K

Holdings After Transaction: Ordinary Shares — 125,958 shares (Direct, null)

Footnotes (1)

Key Figures

Shares sold: 20,000 shares Sale price per share: $11.0002 per share Sale transactions: 2 transactions +1 more

4 metrics

Shares sold 20,000 shares Total Ordinary Shares sold by CFO in open market

Sale price per share $11.0002 per share Reported price for both sale transactions

Sale transactions 2 transactions Number of open-market sale trades reported

Net share change 20,000 shares sold Net-sell direction from transaction summary

Key Terms

Ordinary Shares, open-market sale, transaction code "S", net-sell

4 terms

Ordinary Shares financial

"The filing reports transactions in Ordinary Shares of Alpha Tau Medical."

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

open-market sale financial

"Each transaction is described as an open-market sale of Ordinary Shares."

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

transaction code "S" financial

"The Form 4 uses transaction code "S" for these sales."

net-sell financial

"The transaction summary shows a net-sell direction of 20,000 shares."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/26/2026 - 08:18 AM Accepted by SEC EDGAR 06/26/2026 - 08:17 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Levy Raphi

(Last) (First) (Middle)

C/O ALPHA TAU MEDICAL

PO BOX 45044

(Street)

JERUSALEM 9777605

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Alpha Tau Medical Ltd. [ DRTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	06/25/2026	06/25/2026	S		4,222	D	$11.0002	125,958	D
Ordinary Shares	06/25/2026	06/25/2026	S		15,778	D	$11.0002	110,180	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	Raphi Levy	06/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Alpha Tau Medical (DRTS) report for Raphi Levy?

Alpha Tau Medical reported that CFO Raphi Levy sold 20,000 Ordinary Shares. The Form 4 shows two open-market sale transactions on June 25, 2026, reducing his directly held position in the company’s stock.

How many Alpha Tau Medical (DRTS) shares did the CFO sell and at what price?

Raphi Levy sold a total of 20,000 Ordinary Shares of Alpha Tau Medical. The reported sale price was approximately $11.0002 per share, based on two separate open-market transactions disclosed in the Form 4 filing.

Were Raphi Levy’s Alpha Tau Medical (DRTS) transactions open-market sales?

Yes. The Form 4 identifies both transactions as open-market sales. The transaction code is “S,” with the description stating they are sales in open market or private transactions, indicating discretionary dispositions of Ordinary Shares.

Did the Alpha Tau Medical (DRTS) Form 4 include any derivative transactions?

No. The filing’s derivative transaction data show zero derivative transactions and zero exercised shares. The activity disclosed relates only to non-derivative Ordinary Shares sold in the open market by CFO Raphi Levy.

What is the net share change from the Alpha Tau Medical (DRTS) CFO’s Form 4?

The Form 4 reports a net sale of 20,000 shares. Transaction summary data show two sale transactions totaling 20,000 Ordinary Shares, resulting in a net-sell direction for CFO Raphi Levy’s reported holdings.